We’re excited to announce that Aisthesis Medical has been selected to present at Tech Tour AI for Health 2026, one of Europe’s leading investor-driven platforms for companies applying AI to real clinical challenges.
This selection places us among a competitive cohort of innovators working across prevention, diagnostics, treatment, and acute care. We’ll be in Bochum on 12–13 March 2026 to demonstrate how VIOSync® enables earlier, safer responses to patient deterioration, and to connect with healthcare leaders, corporate partners, and investors shaping the future of clinical AI.
What we’ll be showcasing: VIOSync® for earlier detection and action
VIOSync® is our hospital-grade clinical AI platform for early sepsis detection and acute deterioration management. It combines:
- Predictive Intelligence: Real-time sepsis risk prediction up to 48 hours in advance (depending on setting and data availability)
- Explainable AI (XAI): Transparent outputs designed to support clinician trust, validation, and regulatory auditability
- Workflow Integration: Evidence-based guidance embedded directly into clinical workflows, reducing friction at the bedside, not adding to it
- Multimodal Data Fusion: Integrates vital signs, lab results, and clinical context
Our mission is straightforward: Help clinical teams spot deterioration earlier and act with greater confidence, while enabling scalable adoption across hospital environments.
Why this matters now
Despite increasing awareness, sepsis remains a major driver of preventable harm in hospitals worldwide.
The problem? Detection often happens too late—when the clinical picture is already obvious and the window to prevent organ dysfunction is closing.
The next wave of acute care innovation will be defined by solutions that are predictive (not reactive), explainable (not black-box), integrated (not another standalone dashboard), and evidence-ready (not “pilot forever”).
Tech Tour AI for Health signals that the European healthcare ecosystem is prioritizing exactly these attributes—and we’re excited to contribute to that conversation with a product built for frontline realities.
See You in Bochum
If you’re attending Tech Tour AI for Health 2026, we’d love to connect. Whether you’re interested in clinical collaboration, strategic partnerships, or investment discussions, let’s find time to talk. This is a unique opportunity to showcase our work, exchange insights, and drive forward the next era of AI in healthcare.
Additional details about the event are available at Tech Tour AI for Health.
Stay tuned for updates from Bochum as we take part in this game-changing discussion!
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven sepsis care platform that goes beyond early prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.
Ready to Learn More?
If you’re a hospital, NHS trust, or healthcare investor interested in learning more about VIOSync or our security and compliance posture, we’d love to connect.
📩 Get in touch: https://aisthesismed.com/contact/
🌐 Learn more about VIOSync: https://aisthesismed.com/product/